Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine

Background: Tamoxifen is one of the medicines for adjuvant endocrine therapy of hormone-dependent breast cancer. However, development of resistance to tamoxifen occurs inevitably during treatment. This study aimed to determine whether sensitivity of tamoxifen-resistant breast cancer cells (TAM-R) co...

Full description

Bibliographic Details
Main Authors: Yuntao Wang MS, Wei Yue PhD, Haiyan Lang PhD, Xiaoqing Ding PhD, Xinyi Chen BA, Haiyan Chen PhD
Format: Article
Language:English
Published: SAGE Publishing 2021-03-01
Series:Integrative Cancer Therapies
Online Access:https://doi.org/10.1177/1534735421996822

Similar Items

Similar Items